EGFR and neoplasm: Such studies should consider multiple factors, including VPI, histological type of NSCLC, tumor differentiation, nodule characteristics, lymph node involvement, inflammatory markers, tumor gene mutations (such as EGFR gene mutations), and the degree of VPI.